1 Barry DW,Vaezi MF.Laryngopharyngeal reflux:More ques-tions than answers[J].Cleve Clin J Med,2010,77:327.

2 Gupta R,Sataloff RT.Laryngopharyngeal reflux:current con-cepts and questions[J].Curr Opin Otolaryngol Head Neck Surg,2009,17:143.

3 Sataloff RT,Hawkshaw MJ,Gupta R.Laryngopharyngeal re-flux and voice disorders:an overview on disease mechanisms,treatments,and research advances[J].Discov Med,2010,10:213.

4 Masaany M,Marina MB,Ezat WPS,et al.Empirical treatment with pantoprazole as a diagnostic tool for symptomatic adult la-ryngopharyngeal reflux[J].J Laryngol Otol,2011,125:502.

5 Jin J,Lee YS,Jeong SW,et al.Change of acoustic parameters before and after treatment in laryngopharyngeal reflux patients[J].Laryngoscope,2008,118:938.

6 Altman KW,Prufer N,Vaezi MF.The challenge of protocols for reflux disease:a review and development of a critical path-way[J].Otolaryngol Head Neck Surg,2011,145:7.

7 Ford C,Richter JE,Stasney CR.Treatment of chronic posterior laryngitis with esomeprazole[J].Laryngoscope,2006,116:1717.

8 Nino G,Savchenko O,Vastola P,et al.Lipid laden macrophage indices and reflux finding score in canine gastroesophageal re-flux model[J].Pediatr Pulmonol,2007,42:1 181.

9 Johnston N,Knight J,Dettmar PW,et al.Pepsin and carbonic anhydrase isoenzyme III as diagnostic markers for laryngopha-ryngeal reflux disease[J].Laryngoscope,2004,114:2 129.

10 Wood JM,Hussey DJ,Woods CM,et al.Biomarkers and la-ryngopharyngeal reflux[J].J Laryngol Otol,2011,125:1218.

11 Johnston N,Dulmer D,Gill G,et al.Cell biology of laryngeal epithelial defenses in health and disease:further studies[J].Ann Otol Rhinol Laryngol,2003,112:481.

12 Gill GA,Johnstoti N,Buola A,et al.Laryngeal epithelial de-fenses against laryngopharyngeal reflux:investigations of E-cadherin,carbonic anhydrase isoenzyme III,and pepsin[J].Ann Otol Rhinol Laryngol,2005,114:913.

13 Johnston N,Dettmar PW,Ively MO,et al.Effect of pepsin on laryngeal stress protein(SEP70,SEP53,and Hsp70)re-sponse:role in laryngopharyngeal reflux disease[J].Ann Otol Rhinol Laryngol,2006,115:47.

14 Steward DL,Wilson K,Kelly DH,et al.Proton pump inhibi-tor therapy for chronic laryngo-pharyngitis:a randomized placebo-control trial[J].Otolaryngol Head Neck Surg,2004,131:342.

15 Szczesniak MM,William RBH,Brake HM,et al.Upregulation of the esophago-UES relaxation response:apossible patho-physiological mechanism in suspected reflux laryngitis[J].Neurogastroenterol Motil,2010,22:381.

16 Altman KW,Haines GK,Hammer ND,et al.The H+/K+-ATPase(proton)pump is expressed in human laryngeal sub-mucosal glands[J].Laryngoscope,2003,113:1 927.

17 Ling ZQ,Mukaisho K,Hidaka M,et al.Duodenal contents re-flux-induced laryngitis in rats:possible mechanism of en-hancement of the causative factors in laryngeal carcinogenesis[J].Ann Otol Rhinol Laryngol,2007,116:471.

18 Qadeer MA,Colabianchi N,Strome M,et al.Gastroesophage-al reflux and laryngeal cancer:causation or association?A critical review[J].Am J Otolaryngol,2006,27:119.

19 Altman KW,Prufer N,Vaezi MF.A review of clinical practice guidelines for reflux disease:toward creating a clinical proto-col for the otolaryngologist[J].Laryngoscope,2011,121:717.

20 Reichel O,Issing WJ.Should patients with pH-documented laryngopharyngeal reflux routinely undergo oesophagogas-troduodenoscopy?A retrospective analysis[J].J Laryngol Otol,2007,121:1 165.

21 He Z,Reilly RO,Bolling L,et al.Detection of gastric pepsin in middle ear fluid of children with otitis media[J].Otolaryn-gol Head Neck Surg,2007,137:59.

22 Wang L,Liu X,Liu XL,et al.Correlation of pepsin-meas-ured laryngopharyngeal reflux disease with symptoms and signs[J].Otolaryngol Head Neck Surg,2010,143:765.

23 Ford CN.Evaluation and management of laryngopharyngeal reflux[J].JAMA,2005,294:1 534.

24 Naiboglu B,Durmus R,Tek A,et al.Do the laryngopharynge-al symptoms and signs ameliorate by empiric treatment in pa-tients with suspected laryngopharyngeal reflux[J]?Auris Nasus Larynx,2011,38:622.

25 Lee YS,Choi SH,Son UI,et al.Prospective,observational study using rabeprazole in 455patients with laryngopharyn-geal reflux disease[J].Eur Arch Otorhinolaryngol,2011,268:863.

26 Belafsky PC,Postma GN,Koufman JA.Validity and reliabili-ty of the reflux symptom index(RSI)[J].J Voice,2002,16:274.

27 Belafsky PC,Postma GN,Koufman JA.The validity and relia-bility of the reflux finding score(RFS)[J].Laryngoscope,2001,111:1 313.

28李进让.咽喉反流性疾病的诊断和治疗[J].中华耳鼻咽喉头颈外科杂志,2009,44:172.

29 Ali M.Laryngopharyngeal reflux:diagnosis and treatment of a controversial disease[J].Curr Opin Allergy Clin Immunol,2008,8:28.

30 Reichel O,Issing WJ.Impact of different pH thresholds for 24-hour dual probe pH monitoring in patients with suspected laryngopharyngeal reflux[J].J Laryngol Otol,2008,122:485.

31 Dobhan R,Castell DO.Normal and abnormal proximal esoph-ageal acid exposure:results of ambulatory dual-probe pH monitoring[J].Am J Gastroenterol,1993,88:25.

32 Zerbib F,Stoll D.Management of laryngopharyngeal reflux:an unmet medical need[J].Neurogastroenterol Motil,2010,22:109.

33 Jiang A,Liang MJ,Su ZZ,et al.Immunohistochemical de-tection of pepsin in laryngeal mucosa for diagnosing laryngo-pharyngeal reflux[J].Laryngoscope,2011,121:1 426.

34 Reimer C,Bytzer P.Management of laryngopharyngeal reflux with proton pump inhibitors[J].Therapeutics and Clinical Risk Management,2008,4:225.

35 Friedman M,Schalch P,Vidyasagar R,et al.Wireless upper e-sophageal monitoring for laryngopharyngeal reflux(LPR)[J].Otolaryngol Head Neck Surg,2007,137:471.

36 Karamanolis G,Triantafyllou K,Pastha P,et al.Bravo 48-hour wireless pH monitoring in patients eith non-cardiac chest pain.Objective gastroesophageal reflux disease param-eters predict the responses to proton pump inhibitors[J].J Neurogastroenterol Motil,2012,18:169.

37 Fass R,Noelck N,Willism R,et al.The effect of esomeprazole20mg twice daily on acoustic and perception parameters of the voice in laryngopharyngeal reflux[J].Neurogastroenterol Motil,2010,22:134.

38 Siupsinskiene N,Adamonis K,Toohill RJ.Usefulness of as-sessment of voice capabilities in female patients with reflux-related dysphonia[J].J Medicina(Kaunas),2009,45:978.

39 Ma E,Robortson J,Radford C,et al.Reliability of speaking and maximum voice range measures in screening for dyspho-nia[J].J Voice,2007,21:397.

40 Knight J,Lively MO,Johnston N,et al.Sensitive pepsin im-munoassay for detection of laryngopharyngeal reflux[J].La-ryngoscope,2005,115:1 473.

41 Wassenaar E,Johnston N,Merati A,et al.Pepsin detection in patients with laryngopharyngeal reflux before and after fun-doplication[J].Surg Endosc,2011,25:3 870.

42 Kimura Y,Sugiura M,Kato T,et al.Value of barium swallow studies in predicting the response to rabeprazole in elderly pa-tients with laryngopharyngeal reflux disease and nonerosive reflux disease in particular[J].Ann Otol Rhinol Laryngol,2010,119:631.